<article><p><a href="https://www.dealstreetasia.com/?s=Tata Steel" target="_blank" rel="noopener noreferrer"><strong>Tata Steel</strong></a> has called off its plans to sell majority stake in its Southeast Asia steel business to China&#8217;s state-owned <strong><a href="https://www.dealstreetasia.com/?s=HBIS Group" target="_blank" rel="noopener noreferrer">HBIS Group</a></strong>.</p></article>

Chinese biotech firm Innovent Biologics is looking to raise up to $422 million in its Hong Kong IPO in what could be biggest biotech IPO in the financial hub this year.

Tata Steel cancels deal to sell Southeast Asia steel biz to China's HBIS Group

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Indian court rejects plea against ArcelorMittal's bid for Essar Steel

Thyssenkrupp, Tata Steel JV hits a roadblock, rejected by EU regulators

Read more from India

Indian firms set to raise $2.4b via IPOs this month on renewed confidence

FMO proposes $7.5m investment in Indian MSME-focused lender NeoGrowth